Konrad Krawczyk is the founder of NaturalAntibody, that focuses on computational antibody engineering. Previously he was developing leading computational antibody analysis tools at the University of Oxford. He is a recognized authority in computational antibody design and analysis, having served as a consultant on bioinformatic antibody issues to top research institutions and pharmaceutical companies. He is also an Assistant Professor at SDU in Denmark and lecturer at UCAS in China. His research interests focus on developing computational methods for studying antibodies - specifically, how triangulating structure, binding and developability predictions can be employed to accelerate therapeutic antibody pipelines.